P26363 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifuxwg573mfjq5xcfaf3kcoralwrtul7pbolurxkht4n7su7cnjyu/metadata.json
IPFS of structure file: 
bafybeiglmax6bcfwzfu64mr22pf33ynqy4mrpgq2f4kskc6wn4b3dyzb4e/AF-P26363-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x2212E7C2D74dEcE3Be1026CF82bc07Dd6C6F59a9
First NFT owner address (bech32): 
genesis1ygfw0skhfhkw80ssym8c90q8m4kx7kdf5688m3
Current NFT ID #58998 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
58998
Accession (UniProt):
P26363
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
XENOPUS LAEVIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P26363 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P26363|CFTR_XENLA Cystic fibrosis transmembrane conductance regulator OS=Xenopus laevis OX=8355 GN=cftr PE=2 SV=1 MQKTPLEKASIFSQIFFSWTKPILWKGYRQRLELSDIYQIHPGDSADNLSERLEREWDREVATSKKNPKLINALKRCFFWKFLFYGILLYLGEVTKAVQPLLLGRIIASYDRDNEHERSIAYYLAIGLCLLFVVRMLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSKVLDKISTGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVLLLMGLLWDLLQASAFCGLGFLIILSLFQARLGRMMMKYKDKRAGKINERLVITSQIIENIQSVKAYCWENAMEKIIETIRETELKLTRKAAYVRYFNSSAFFFSGFFVVFLSIVPHLLLDGISLRKIFTTISFSIVLRMAVTRQFPWAVQTWYDSLGVINKIQEFLQKEEYKSLEYNLTTTEVAMENVSASWDEGIGEFFEKAKLEVNGGNISNEDPSAFFSNFSLHVAPVLRNINFKIEKGQLLAIAGSTGAGKTSLLMMIMGELEPSAGKIKHSGRISFSPQVSWIMPGTIKENIVFGVSYDQYRYLSVIKACQLEEDISKFPEKDNTVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFSYLDLFTEKEIFESCVCKLMANKTRILVTSKVEQLKKADKVLILHEGSCYFYGTFSELEDQRPEFSSHLIGFDHFNAERRNSIITETLRRCSIDSDPSAVRNEVKNKSFKQVADFTEKRKSSIINPRKSSRKFSLMQKSQPQMSGIEEEDMPAEQGERKLSLVPESEQGEASLPRSNFLNTGPTFQGRRRQSVLNLMTRTSISQGSNAFATRNASVRKMSVNSYSNSSFDLDIYNRRLSQDSILEVSEEINEEDLKECFLDDTDSQSPTTTWNTYLRFLTAHKNFIFILVFCLVIFFVEVAASSAWLWIIKRNAPAINMTSNENVSEVSDTLSVIVTHTSFYYVFYIYVGVADSLLALGIFRGLPLVHSLISVSKVLHKKMLHAILHAPMSTFNTMRAGRILNRFSKDTAILDDILPLSIFDLTQLVLIVIGAITVVSLLEPYIFLATVPVIVAFILLRSYFLHTSQQLKQLESKARSPIFAHLITSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMTIEMIFVIFFIAVSFISIATSGAGEEKVGIVLTLAMNIMNTLQWAVNASIDVDSLMRSVSRIFRFIDLPVEELINENKNKEEQLSEVLIYENDYVKKTQVWPSGGQMTVKNLSANYIDGGNTVLENISFSLSPGQRVGLLGRTGSGKSTLLSAFLRLLSTQGDIQIDGVSWQTIPLQKWRKAFGVIPQKVFIFSGSIRKNLDPYGKWSDEELLKVTEEVGLKLIIDQFPGQLDFVLLDGGCVLSHGHKQLVCLARSVLSKAKILLLDEPSAHLDPITFQIIRKTLKHAFADCTVILSEHRLEAMLECQRFLVIEDNTVRQYDSIQKLVNEKSFFKQAISHSDRLKLFPLHRRNSSKRKSRPQISALQEETEEEVQDTRL